Discover Vicebio's molecular clamp technology as it completes a $100 million series B round for its bivalent vaccine against ...

The former head of vaccine R&D at GSK has pulled together $100 million for a London-based biotech working on respiratory ...

The global tinea pedis treatment market is on a robust growth trajectory, projected to reach a market value of USD 2,484 ...

In the last year, for instance, GSK, Pfizer and more recently Moderna have all brought to market shots for RSV, a common ...

Peripheral blood mononuclear cells (PBMCs) collected from 10 patients with active AS patients were exposed to TP, GSK-J4 or vehicle. T lymphocyte subsets were analyzed using flow cytometry. ELISA was ...

Allison Freedman is opening up about her fight with multiple myeloma during Blood Cancer Awareness Month. She went from being ...

The GSK share price has had a rotten few years and now it's heading south yet again. Investor Harvey Jones continues to hang ...

Everything we covered on WTR over the past seven days, and all you need to know from the world of trademarks to set yourself up for the start of another busy week.

Niger has become the latest West African country to roll out malaria vaccines to try to stifle the potentially deadly disease ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...